IVECO GROUP NV (IVG.MI) Stock Fundamental Analysis
Europe - BIT:IVG - NL0015000LU4 - Common Stock
18.4 EUR
-0.02 (-0.11%)
Taking everything into account, IVG scores 4 out of 10 in our fundamental rating. IVG was compared to 109 industry peers in the Machinery industry. There are concerns on the financial health of IVG while its profitability can be described as average. IVG has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year IVG was profitable.
In the past year IVG had a positive cash flow from operations.
Of the past 5 years IVG 4 years were profitable.
Each year in the past 5 years IVG had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.73%, IVG is in line with its industry, outperforming 41.82% of the companies in the same industry.
IVG has a Return On Equity of 12.39%. This is in the better half of the industry: IVG outperforms 74.55% of its industry peers.
The Return On Invested Capital of IVG (4.53%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for IVG is below the industry average of 8.90%.
The 3 year average ROIC (3.91%) for IVG is below the current ROIC(4.53%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.73% | ||
| ROE | 12.39% | ||
| ROIC | 4.53% |
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
1.3 Margins
IVG's Profit Margin of 2.17% is on the low side compared to the rest of the industry. IVG is outperformed by 60.00% of its industry peers.
In the last couple of years the Profit Margin of IVG has grown nicely.
Looking at the Operating Margin, with a value of 5.00%, IVG is in line with its industry, outperforming 44.55% of the companies in the same industry.
IVG's Operating Margin has improved in the last couple of years.
IVG has a worse Gross Margin (16.49%) than 89.09% of its industry peers.
In the last couple of years the Gross Margin of IVG has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5% | ||
| PM (TTM) | 2.17% | ||
| GM | 16.49% |
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IVG is destroying value.
The number of shares outstanding for IVG has been reduced compared to 1 year ago.
IVG has more shares outstanding than it did 5 years ago.
IVG has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.76, we must say that IVG is in the distress zone and has some risk of bankruptcy.
IVG's Altman-Z score of 1.76 is in line compared to the rest of the industry. IVG outperforms 44.55% of its industry peers.
The Debt to FCF ratio of IVG is 14.82, which is on the high side as it means it would take IVG, 14.82 years of fcf income to pay off all of its debts.
IVG has a worse Debt to FCF ratio (14.82) than 68.18% of its industry peers.
IVG has a Debt/Equity ratio of 1.35. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.35, IVG is not doing good in the industry: 81.82% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.35 | ||
| Debt/FCF | 14.82 | ||
| Altman-Z | 1.76 |
ROIC/WACC0.64
WACC7.06%
2.3 Liquidity
IVG has a Current Ratio of 1.98. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.98, IVG is doing good in the industry, outperforming 78.18% of the companies in the same industry.
A Quick Ratio of 1.40 indicates that IVG should not have too much problems paying its short term obligations.
IVG's Quick ratio of 1.40 is amongst the best of the industry. IVG outperforms 82.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.4 |
3. Growth
3.1 Past
IVG shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.95%.
Measured over the past years, IVG shows a very strong growth in Earnings Per Share. The EPS has been growing by 32.82% on average per year.
The Revenue has decreased by -6.97% in the past year.
The Revenue has been growing slightly by 5.06% on average over the past years.
EPS 1Y (TTM)-5.95%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-38.1%
Revenue 1Y (TTM)-6.97%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-3.52%
3.2 Future
IVG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.81% yearly.
Based on estimates for the next years, IVG will show a small growth in Revenue. The Revenue will grow by 4.30% on average per year.
EPS Next Y-12.5%
EPS Next 2Y6.41%
EPS Next 3Y9.46%
EPS Next 5Y10.81%
Revenue Next Year-2.33%
Revenue Next 2Y2.71%
Revenue Next 3Y3.58%
Revenue Next 5Y4.3%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 11.65 indicates a reasonable valuation of IVG.
Based on the Price/Earnings ratio, IVG is valued cheaply inside the industry as 84.55% of the companies are valued more expensively.
IVG is valuated cheaply when we compare the Price/Earnings ratio to 26.06, which is the current average of the S&P500 Index.
IVG is valuated cheaply with a Price/Forward Earnings ratio of 7.81.
89.09% of the companies in the same industry are more expensive than IVG, based on the Price/Forward Earnings ratio.
IVG is valuated cheaply when we compare the Price/Forward Earnings ratio to 32.73, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.65 | ||
| Fwd PE | 7.81 |
4.2 Price Multiples
77.27% of the companies in the same industry are more expensive than IVG, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, IVG is valued a bit cheaper than the industry average as 70.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.48 | ||
| EV/EBITDA | 5.5 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)0.35
EPS Next 2Y6.41%
EPS Next 3Y9.46%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.79%, IVG has a reasonable but not impressive dividend return.
IVG's Dividend Yield is comparable with the industry average which is at 2.60.
IVG's Dividend Yield is slightly below the S&P500 average, which is at 2.37.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.79% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
27.33% of the earnings are spent on dividend by IVG. This is a low number and sustainable payout ratio.
DP27.33%
EPS Next 2Y6.41%
EPS Next 3Y9.46%
BIT:IVG (11/7/2025, 7:00:00 PM)
18.4
-0.02 (-0.11%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners39.4%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap4.99B
Revenue(TTM)14.81B
Net Income(TTM)322.00M
Analysts73.33
Price Target20.08 (9.13%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.79% |
Yearly Dividend0.27
Dividend Growth(5Y)N/A
DP27.33%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.8%
Min EPS beat(2)-15.44%
Max EPS beat(2)5.84%
EPS beat(4)3
Avg EPS beat(4)15.3%
Min EPS beat(4)-15.44%
Max EPS beat(4)63.53%
EPS beat(8)5
Avg EPS beat(8)15.63%
EPS beat(12)8
Avg EPS beat(12)16.7%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.77%
Min Revenue beat(2)-10.1%
Max Revenue beat(2)8.56%
Revenue beat(4)3
Avg Revenue beat(4)2.17%
Min Revenue beat(4)-10.1%
Max Revenue beat(4)9.28%
Revenue beat(8)5
Avg Revenue beat(8)0.74%
Revenue beat(12)7
Avg Revenue beat(12)2.33%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.3%
EPS NY rev (1m)-2.91%
EPS NY rev (3m)-9.14%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.67%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.54%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.65 | ||
| Fwd PE | 7.81 | ||
| P/S | 0.34 | ||
| P/FCF | 12.48 | ||
| P/OCF | 3.87 | ||
| P/B | 1.92 | ||
| P/tB | 9.04 | ||
| EV/EBITDA | 5.5 |
EPS(TTM)1.58
EY8.59%
EPS(NY)2.36
Fwd EY12.8%
FCF(TTM)1.47
FCFY8.02%
OCF(TTM)4.75
OCFY25.83%
SpS54.61
BVpS9.58
TBVpS2.04
PEG (NY)N/A
PEG (5Y)0.35
Graham Number18.46
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.73% | ||
| ROE | 12.39% | ||
| ROCE | 6% | ||
| ROIC | 4.53% | ||
| ROICexc | 5.79% | ||
| ROICexgc | 7.34% | ||
| OM | 5% | ||
| PM (TTM) | 2.17% | ||
| GM | 16.49% | ||
| FCFM | 2.7% |
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
ROICexc(3y)4.85%
ROICexc(5y)N/A
ROICexgc(3y)5.77%
ROICexgc(5y)N/A
ROCE(3y)5.17%
ROCE(5y)N/A
ROICexgc growth 3Y26.65%
ROICexgc growth 5Y12.05%
ROICexc growth 3Y25.45%
ROICexc growth 5Y11.07%
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
F-Score6
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.35 | ||
| Debt/FCF | 14.82 | ||
| Debt/EBITDA | 2.37 | ||
| Cap/Depr | 119.97% | ||
| Cap/Sales | 6% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 86.98% | ||
| Profit Quality | 124.22% | ||
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.4 | ||
| Altman-Z | 1.76 |
F-Score6
WACC7.06%
ROIC/WACC0.64
Cap/Depr(3y)146.94%
Cap/Depr(5y)121.88%
Cap/Sales(3y)5.9%
Cap/Sales(5y)5.2%
Profit Quality(3y)212.1%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.95%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-38.1%
EPS Next Y-12.5%
EPS Next 2Y6.41%
EPS Next 3Y9.46%
EPS Next 5Y10.81%
Revenue 1Y (TTM)-6.97%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-3.52%
Revenue Next Year-2.33%
Revenue Next 2Y2.71%
Revenue Next 3Y3.58%
Revenue Next 5Y4.3%
EBIT growth 1Y-21.25%
EBIT growth 3Y38.23%
EBIT growth 5Y15.55%
EBIT Next Year74.95%
EBIT Next 3Y29.26%
EBIT Next 5YN/A
FCF growth 1Y-7.83%
FCF growth 3YN/A
FCF growth 5Y-8.52%
OCF growth 1Y-0.31%
OCF growth 3Y26.42%
OCF growth 5Y8.96%
IVECO GROUP NV / IVG.MI FAQ
Can you provide the ChartMill fundamental rating for IVECO GROUP NV?
ChartMill assigns a fundamental rating of 4 / 10 to IVG.MI.
Can you provide the valuation status for IVECO GROUP NV?
ChartMill assigns a valuation rating of 6 / 10 to IVECO GROUP NV (IVG.MI). This can be considered as Fairly Valued.
What is the profitability of IVG stock?
IVECO GROUP NV (IVG.MI) has a profitability rating of 5 / 10.
Can you provide the financial health for IVG stock?
The financial health rating of IVECO GROUP NV (IVG.MI) is 3 / 10.
What is the earnings growth outlook for IVECO GROUP NV?
The Earnings per Share (EPS) of IVECO GROUP NV (IVG.MI) is expected to decline by -12.5% in the next year.